Treatments for Wet Macular Degeneration

Macugen was the first antiangiogenic therapy to be approved by the FDA. It was shown to be effective in 70% of cases, but did not restore vision in any statistically significant amount.

Lucentis approved since 2008. Shot given every 4 weeks. 95% effective.

Avastin similar to Lucentis but much less expensive

Eyelea approved since 2011. Shot given every 8 weeks.

Photodynamic Therapy (PDT) is a cold laser + dye treatment that is still being used to treat patients with wet AMD, though much less frequently now that useful drugs are available.

Photocoagulation Therapy is a “hot laser” treatment. With the advent of newer therapies, very few “hot” lasers are performed. For years, photocoagulation was the only treatment available for wet AMD.

For more info:


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: